| Year |
Citation |
Score |
| 2021 |
Hung KL, Yost KE, Xie L, Shi Q, Helmsauer K, Luebeck J, Schöpflin R, Lange JT, Chamorro González R, Weiser NE, Chen C, Valieva ME, Wong IT, Wu S, Dehkordi SR, ... ... Bagchi A, et al. ecDNA hubs drive cooperative intermolecular oncogene expression. Nature. PMID 34819668 DOI: 10.1038/s41586-021-04116-8 |
0.452 |
|
| 2021 |
McAloney CA, Silverstein KAT, Modiano JF, Bagchi A. Correction to: Polymorphisms within the Telomerase Reverse Transcriptase gene (TERT) in four breeds of dogs selected for difference in lifespan and cancer susceptibility. Bmc Veterinary Research. 17: 297. PMID 34488767 DOI: 10.1186/s12917-021-03002-9 |
0.345 |
|
| 2020 |
Tiwari A, Tashiro K, Dixit A, Soni A, Vogel K, Hall B, Shafqat I, Slaughter J, Param N, Le A, Saunders E, Paithane U, Garcia G, Campos AR, Zettervall J, ... ... Bagchi A, et al. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis. Gastroenterology. PMID 32768595 DOI: 10.1053/j.gastro.2020.07.046 |
0.304 |
|
| 2019 |
Tseng YY, Bagchi A. Engineering Large Genomic Rearrangement in Mouse Embryonic Stem Cell for Cancer Gene Discovery. Methods in Molecular Biology (Clifton, N.J.). 1907: 197-212. PMID 30543002 DOI: 10.1007/978-1-4939-8967-6_16 |
0.736 |
|
| 2019 |
Argueta DA, Aich A, Lei J, Nekhai S, Ammosova T, Lin X, Bagchi A, Gupta K. Downregulation of Sprr1a Contributes to the Pathobiology of Sickle Cell Disease Blood. 134: 75-75. DOI: 10.1182/Blood-2019-129004 |
0.314 |
|
| 2017 |
Paul JA, Aich A, Abrahante JE, Wang Y, LaRue RS, Rathe SK, Kalland K, Mittal A, Jha R, Peng F, Largaespada DA, Bagchi A, Gupta K. Transcriptomic analysis of gene signatures associated with sickle pain. Scientific Data. 4: 170051. PMID 29292796 DOI: 10.1038/Sdata.2017.51 |
0.312 |
|
| 2017 |
Tashiro K, Tseng Y, Konety B, Bagchi A. MP99-18 ROLE OF LONG NON-CODING RNA PVT1 IN REGULATING MYC IN HUMAN CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3104 |
0.714 |
|
| 2016 |
Sarver AL, Murray CD, Temiz NA, Tseng YY, Bagchi A. MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer. Cell Cycle (Georgetown, Tex.). 0. PMID 26889781 DOI: 10.1080/15384101.2016.1149660 |
0.759 |
|
| 2016 |
Tashiro K, Leary R, Bagchi A. Abstract B025: p53 responsive endogeneous retrovirus as early mediators of immunosurveillance Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B025 |
0.424 |
|
| 2016 |
Zhang F, Song W, Li S, Ajay V, Aguilo F, Bagchi A, Wohlschlegel JA, Zhang B, Walsh M. Abstract PR06: The enhancer landscape involves a core noncoding RNA protein interaction network forC-MYCexpression Cancer Research. 76. DOI: 10.1158/1538-7445.Nonrna15-Pr06 |
0.566 |
|
| 2016 |
Tashiro K, Klink R, Zetterval J, Diedrich V, Tseng Y, Bagchi A. Abstract 2663: Insights into the oncogenic basis of long non-coding RNA PVT1 in human cancer Cancer Research. 76: 2663-2663. DOI: 10.1158/1538-7445.Am2016-2663 |
0.796 |
|
| 2015 |
Tseng YY, Bagchi A. The PVT1-MYC duet in cancer. Molecular & Cellular Oncology. 2: e974467. PMID 27308428 DOI: 10.4161/23723556.2014.974467 |
0.758 |
|
| 2015 |
Tseng Y, Bagchi A. Abstract PR01: Long noncoding RNA PVT1 potentiates MYC in human cancers with 8q24 gain Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Pr01 |
0.796 |
|
| 2015 |
Peacock J, Bagchi A, Egan S, Taylor M. PM-16AN ANIMAL MODEL OF 17p DELETION IN MEDULLOBLASTOMA Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov061.138 |
0.48 |
|
| 2014 |
Tseng YY, Moriarity BS, Gong W, Akiyama R, Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell TC, Essig J, Otto GM, O'Sullivan MG, Largaespada DA, Schwertfeger KL, ... ... Bagchi A, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 512: 82-6. PMID 25043044 DOI: 10.1038/Nature13311 |
0.778 |
|
| 2014 |
McAloney CA, Silverstein KA, Modiano JF, Bagchi A. Polymorphisms within the Telomerase Reverse Transcriptase gene (TERT) in four breeds of dogs selected for difference in lifespan and cancer susceptibility. Bmc Veterinary Research. 10: 20. PMID 24423165 DOI: 10.1186/1746-6148-10-20 |
0.495 |
|
| 2012 |
Tseng Y, Beadnell T, Schwertfeger K, Bagchi A. Abstract 3288: A chromosome engineering mouse model to identify mechanisms by which duplication of 8q24 promotes human breast cancer Cancer Research. 72: 3288-3288. DOI: 10.1158/1538-7445.Am2012-3288 |
0.733 |
|
| 2011 |
Billington CJ, Ng B, Forsman C, Schmidt B, Bagchi A, Symer DE, Schotta G, Gopalakrishnan R, Sarver AL, Petryk A. The molecular and cellular basis of variable craniofacial phenotypes and their genetic rescue in Twisted gastrulation mutant mice. Developmental Biology. 355: 21-31. PMID 21549111 DOI: 10.1016/J.Ydbio.2011.04.026 |
0.339 |
|
| 2010 |
Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nature Cell Biology. 12: 1108-14. PMID 20935635 DOI: 10.1038/Ncb2116 |
0.337 |
|
| 2010 |
Tseng Y, Schwertfeger KL, Bagchi A. Abstract 3272: Chromosome engineered mouse model for human 8q24 amplicon observed in breast cancer patients Cancer Research. 70: 3272-3272. DOI: 10.1158/1538-7445.Am10-3272 |
0.757 |
|
| 2008 |
Bagchi A, Mills AA. The quest for the 1p36 tumor suppressor. Cancer Research. 68: 2551-6. PMID 18413720 DOI: 10.1158/0008-5472.CAN-07-2095 |
0.354 |
|
| 2007 |
Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA. CHD5 is a tumor suppressor at human 1p36. Cell. 128: 459-75. PMID 17289567 DOI: 10.1016/j.cell.2006.11.052 |
0.428 |
|
| Show low-probability matches. |